Structure

Physi-Chem Properties

Molecular Weight:  460.17
Volume:  456.011
LogP:  4.483
LogD:  1.534
LogS:  -3.036
# Rotatable Bonds:  5
TPSA:  153.75
# H-Bond Aceptor:  9
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.424
Synthetic Accessibility Score:  3.817
Fsp3:  0.417
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.868
MDCK Permeability:  1.0053789992525708e-05
Pgp-inhibitor:  0.49
Pgp-substrate:  0.891
Human Intestinal Absorption (HIA):  0.516
20% Bioavailability (F20%):  0.106
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.002
Plasma Protein Binding (PPB):  98.23192596435547%
Volume Distribution (VD):  0.375
Pgp-substrate:  4.079526901245117%

ADMET: Metabolism

CYP1A2-inhibitor:  0.063
CYP1A2-substrate:  0.77
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.177
CYP2C9-inhibitor:  0.287
CYP2C9-substrate:  0.617
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.158
CYP3A4-inhibitor:  0.096
CYP3A4-substrate:  0.439

ADMET: Excretion

Clearance (CL):  3.844
Half-life (T1/2):  0.202

ADMET: Toxicity

hERG Blockers:  0.003
Human Hepatotoxicity (H-HT):  0.473
Drug-inuced Liver Injury (DILI):  0.878
AMES Toxicity:  0.029
Rat Oral Acute Toxicity:  0.057
Maximum Recommended Daily Dose:  0.046
Skin Sensitization:  0.927
Carcinogencity:  0.05
Eye Corrosion:  0.003
Eye Irritation:  0.757
Respiratory Toxicity:  0.117

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC112749

Natural Product ID:  NPC112749
Common Name*:   Isomallotochromanol
IUPAC Name:   1-[3-[(6-acetyl-3,5,7-trihydroxy-2,2-dimethyl-3,4-dihydrochromen-8-yl)methyl]-2,6-dihydroxy-4-methoxy-5-methylphenyl]ethanone
Synonyms:   Isomallotochromanol
Standard InCHIKey:  XBXKUYYCBXJGEN-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C24H28O9/c1-9-18(28)16(10(2)25)19(29)12(22(9)32-6)7-13-20(30)17(11(3)26)21(31)14-8-15(27)24(4,5)33-23(13)14/h15,27-31H,7-8H2,1-6H3
SMILES:  COc1c(Cc2c3OC(C)(C)C(Cc3c(c(c2O)C(=O)C)O)O)c(O)c(c(c1C)O)C(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL523152
PubChem CID:   159574
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0001831] Carbonyl compounds
          • [CHEMONTID:0000118] Ketones
            • [CHEMONTID:0003670] Aryl ketones
              • [CHEMONTID:0004296] Phenylketones
                • [CHEMONTID:0004298] Alkyl-phenylketones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[11520216]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[1800639]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. pericarp n.a. PMID[2347013]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[3210017]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[3734813]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[4040956]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26880 Mallotus japonicus Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 100.0 % PMID[467805]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 95.5 % PMID[467805]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 0.0 % PMID[467805]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC112749 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9441 High Similarity NPC472345
0.9433 High Similarity NPC18886
0.9379 High Similarity NPC471677
0.9379 High Similarity NPC474021
0.9379 High Similarity NPC471676
0.9379 High Similarity NPC472420
0.9379 High Similarity NPC474023
0.9379 High Similarity NPC244577
0.9379 High Similarity NPC263384
0.9379 High Similarity NPC472422
0.9315 High Similarity NPC56232
0.9315 High Similarity NPC10807
0.9315 High Similarity NPC475790
0.9315 High Similarity NPC150123
0.9315 High Similarity NPC161881
0.9315 High Similarity NPC244583
0.931 High Similarity NPC105136
0.9306 High Similarity NPC10097
0.9257 High Similarity NPC215917
0.9257 High Similarity NPC10754
0.9257 High Similarity NPC20530
0.9252 High Similarity NPC7989
0.9252 High Similarity NPC469405
0.9252 High Similarity NPC180301
0.9252 High Similarity NPC223701
0.9252 High Similarity NPC248793
0.9252 High Similarity NPC472583
0.9247 High Similarity NPC472636
0.9247 High Similarity NPC262039
0.9247 High Similarity NPC262038
0.9247 High Similarity NPC477897
0.9247 High Similarity NPC328740
0.9247 High Similarity NPC254412
0.9247 High Similarity NPC289774
0.9247 High Similarity NPC278476
0.9247 High Similarity NPC319910
0.9247 High Similarity NPC209846
0.9241 High Similarity NPC139966
0.9241 High Similarity NPC89442
0.9241 High Similarity NPC472628
0.9241 High Similarity NPC307052
0.9236 High Similarity NPC47388
0.9236 High Similarity NPC472627
0.9236 High Similarity NPC473133
0.9236 High Similarity NPC470670
0.9236 High Similarity NPC85773
0.9236 High Similarity NPC91902
0.9231 High Similarity NPC470890
0.9225 High Similarity NPC276565
0.9189 High Similarity NPC259710
0.9189 High Similarity NPC304207
0.9189 High Similarity NPC304745
0.9189 High Similarity NPC207809
0.9189 High Similarity NPC470681
0.9189 High Similarity NPC477958
0.9189 High Similarity NPC111341
0.9189 High Similarity NPC48579
0.9189 High Similarity NPC217706
0.9184 High Similarity NPC243171
0.9184 High Similarity NPC138288
0.9184 High Similarity NPC216035
0.9184 High Similarity NPC171651
0.9184 High Similarity NPC35567
0.9184 High Similarity NPC473996
0.9184 High Similarity NPC217149
0.9178 High Similarity NPC476509
0.9167 High Similarity NPC474302
0.9167 High Similarity NPC472629
0.9155 High Similarity NPC157497
0.9155 High Similarity NPC285659
0.9155 High Similarity NPC74397
0.9155 High Similarity NPC81337
0.9122 High Similarity NPC293286
0.9122 High Similarity NPC268193
0.9122 High Similarity NPC112701
0.9122 High Similarity NPC109594
0.9122 High Similarity NPC326592
0.9116 High Similarity NPC472580
0.9116 High Similarity NPC474772
0.9116 High Similarity NPC472423
0.9116 High Similarity NPC471675
0.9116 High Similarity NPC474744
0.9097 High Similarity NPC124780
0.9097 High Similarity NPC87486
0.9097 High Similarity NPC224714
0.9078 High Similarity NPC248995
0.9078 High Similarity NPC254168
0.9078 High Similarity NPC272844
0.9073 High Similarity NPC472631
0.9073 High Similarity NPC472630
0.9054 High Similarity NPC256141
0.9054 High Similarity NPC477957
0.9054 High Similarity NPC31627
0.9054 High Similarity NPC476238
0.9054 High Similarity NPC285623
0.9054 High Similarity NPC210597
0.9054 High Similarity NPC327269
0.9048 High Similarity NPC472421
0.9048 High Similarity NPC177308
0.9048 High Similarity NPC124478
0.9048 High Similarity NPC38775
0.9034 High Similarity NPC290133
0.9034 High Similarity NPC316769
0.9034 High Similarity NPC24136
0.9034 High Similarity NPC187282
0.9028 High Similarity NPC316816
0.9028 High Similarity NPC478086
0.9028 High Similarity NPC214166
0.9021 High Similarity NPC96408
0.9021 High Similarity NPC156190
0.9021 High Similarity NPC248372
0.9021 High Similarity NPC166689
0.9021 High Similarity NPC17170
0.9021 High Similarity NPC279650
0.9021 High Similarity NPC258630
0.9021 High Similarity NPC110038
0.9014 High Similarity NPC240305
0.9013 High Similarity NPC472634
0.9007 High Similarity NPC473990
0.9 High Similarity NPC208152
0.9 High Similarity NPC78492
0.8993 High Similarity NPC74924
0.8993 High Similarity NPC236756
0.8993 High Similarity NPC100134
0.8993 High Similarity NPC209760
0.8993 High Similarity NPC88983
0.8993 High Similarity NPC20907
0.8993 High Similarity NPC311579
0.8993 High Similarity NPC244250
0.898 High Similarity NPC5173
0.8978 High Similarity NPC186628
0.8973 High Similarity NPC122828
0.8973 High Similarity NPC211466
0.8973 High Similarity NPC51070
0.8973 High Similarity NPC202494
0.8973 High Similarity NPC176869
0.8973 High Similarity NPC40086
0.8973 High Similarity NPC3779
0.8973 High Similarity NPC44721
0.8973 High Similarity NPC296998
0.8973 High Similarity NPC476182
0.8973 High Similarity NPC472918
0.8973 High Similarity NPC473077
0.8973 High Similarity NPC222298
0.8966 High Similarity NPC131579
0.8966 High Similarity NPC131568
0.8966 High Similarity NPC209040
0.8958 High Similarity NPC223500
0.8958 High Similarity NPC220998
0.8958 High Similarity NPC227579
0.8958 High Similarity NPC66515
0.8958 High Similarity NPC228504
0.8958 High Similarity NPC265040
0.8958 High Similarity NPC1089
0.8958 High Similarity NPC64915
0.8958 High Similarity NPC328164
0.8958 High Similarity NPC10937
0.8958 High Similarity NPC32739
0.8958 High Similarity NPC182852
0.8958 High Similarity NPC166934
0.8958 High Similarity NPC40833
0.8958 High Similarity NPC148757
0.8958 High Similarity NPC37496
0.8958 High Similarity NPC76372
0.8958 High Similarity NPC324134
0.8958 High Similarity NPC306829
0.8958 High Similarity NPC161506
0.8958 High Similarity NPC76338
0.8958 High Similarity NPC296917
0.8958 High Similarity NPC125855
0.8958 High Similarity NPC78
0.8958 High Similarity NPC177354
0.8958 High Similarity NPC107572
0.8958 High Similarity NPC167624
0.8958 High Similarity NPC194432
0.8958 High Similarity NPC166482
0.8958 High Similarity NPC324436
0.8954 High Similarity NPC472635
0.8947 High Similarity NPC470326
0.8947 High Similarity NPC174953
0.8947 High Similarity NPC471976
0.8947 High Similarity NPC475784
0.894 High Similarity NPC27337
0.894 High Similarity NPC474055
0.894 High Similarity NPC23817
0.894 High Similarity NPC472598
0.8936 High Similarity NPC470982
0.8936 High Similarity NPC470983
0.8933 High Similarity NPC321779
0.8933 High Similarity NPC470604
0.8933 High Similarity NPC108937
0.8933 High Similarity NPC477530
0.8933 High Similarity NPC470605
0.8933 High Similarity NPC470603
0.8933 High Similarity NPC279218
0.8933 High Similarity NPC470327
0.8933 High Similarity NPC471116
0.8933 High Similarity NPC45849
0.8933 High Similarity NPC200761
0.8933 High Similarity NPC476169

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC112749 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9048 High Similarity NPD4380 Phase 2
0.8867 High Similarity NPD2393 Clinical (unspecified phase)
0.8816 High Similarity NPD7075 Discontinued
0.8707 High Similarity NPD4378 Clinical (unspecified phase)
0.8693 High Similarity NPD4381 Clinical (unspecified phase)
0.8675 High Similarity NPD1934 Approved
0.8675 High Similarity NPD6801 Discontinued
0.8618 High Similarity NPD7096 Clinical (unspecified phase)
0.8611 High Similarity NPD1552 Clinical (unspecified phase)
0.8611 High Similarity NPD1550 Clinical (unspecified phase)
0.8581 High Similarity NPD7410 Clinical (unspecified phase)
0.8562 High Similarity NPD8443 Clinical (unspecified phase)
0.8553 High Similarity NPD7804 Clinical (unspecified phase)
0.8552 High Similarity NPD1549 Phase 2
0.8481 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8481 Intermediate Similarity NPD6166 Phase 2
0.8481 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD6651 Approved
0.8408 Intermediate Similarity NPD6959 Discontinued
0.8367 Intermediate Similarity NPD2800 Approved
0.8366 Intermediate Similarity NPD7411 Suspended
0.8288 Intermediate Similarity NPD2796 Approved
0.8272 Intermediate Similarity NPD7074 Phase 3
0.8258 Intermediate Similarity NPD7819 Suspended
0.8258 Intermediate Similarity NPD2801 Approved
0.8219 Intermediate Similarity NPD1510 Phase 2
0.821 Intermediate Similarity NPD7054 Approved
0.8171 Intermediate Similarity NPD6559 Discontinued
0.816 Intermediate Similarity NPD7472 Approved
0.8153 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD3818 Discontinued
0.8146 Intermediate Similarity NPD1511 Approved
0.8146 Intermediate Similarity NPD6799 Approved
0.811 Intermediate Similarity NPD6797 Phase 2
0.8089 Intermediate Similarity NPD3817 Phase 2
0.8069 Intermediate Similarity NPD1240 Approved
0.8061 Intermediate Similarity NPD7251 Discontinued
0.8039 Intermediate Similarity NPD1512 Approved
0.8038 Intermediate Similarity NPD3882 Suspended
0.8025 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7808 Phase 3
0.8 Intermediate Similarity NPD5494 Approved
0.7987 Intermediate Similarity NPD5403 Approved
0.7974 Intermediate Similarity NPD2532 Approved
0.7974 Intermediate Similarity NPD2534 Approved
0.7974 Intermediate Similarity NPD2533 Approved
0.7959 Intermediate Similarity NPD1607 Approved
0.7949 Intermediate Similarity NPD6599 Discontinued
0.7904 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD5402 Approved
0.7857 Intermediate Similarity NPD5401 Approved
0.7812 Intermediate Similarity NPD7768 Phase 2
0.7791 Intermediate Similarity NPD6232 Discontinued
0.7784 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD5844 Phase 1
0.7763 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD7473 Discontinued
0.7712 Intermediate Similarity NPD4628 Phase 3
0.7654 Intermediate Similarity NPD3749 Approved
0.7651 Intermediate Similarity NPD5124 Phase 1
0.7651 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD920 Approved
0.7597 Intermediate Similarity NPD3750 Approved
0.7588 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD1465 Phase 2
0.7574 Intermediate Similarity NPD5953 Discontinued
0.7568 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD2935 Discontinued
0.7566 Intermediate Similarity NPD1551 Phase 2
0.756 Intermediate Similarity NPD7286 Phase 2
0.7543 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD1243 Approved
0.7486 Intermediate Similarity NPD7584 Approved
0.7472 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD5710 Approved
0.747 Intermediate Similarity NPD5711 Approved
0.7467 Intermediate Similarity NPD1613 Approved
0.7467 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD4360 Phase 2
0.7458 Intermediate Similarity NPD4363 Phase 3
0.7451 Intermediate Similarity NPD6100 Approved
0.7451 Intermediate Similarity NPD6099 Approved
0.745 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD2313 Discontinued
0.7405 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD2799 Discontinued
0.7386 Intermediate Similarity NPD7033 Discontinued
0.7372 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2424 Discontinued
0.7342 Intermediate Similarity NPD7390 Discontinued
0.7341 Intermediate Similarity NPD8313 Approved
0.7341 Intermediate Similarity NPD8312 Approved
0.7329 Intermediate Similarity NPD3226 Approved
0.7315 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD1247 Approved
0.7294 Intermediate Similarity NPD3751 Discontinued
0.729 Intermediate Similarity NPD2344 Approved
0.729 Intermediate Similarity NPD2346 Discontinued
0.7289 Intermediate Similarity NPD919 Approved
0.7273 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3748 Approved
0.7262 Intermediate Similarity NPD3787 Discontinued
0.7261 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD8455 Phase 2
0.7253 Intermediate Similarity NPD6780 Approved
0.7253 Intermediate Similarity NPD6781 Approved
0.7253 Intermediate Similarity NPD6777 Approved
0.7253 Intermediate Similarity NPD6776 Approved
0.7253 Intermediate Similarity NPD6778 Approved
0.7253 Intermediate Similarity NPD6779 Approved
0.7253 Intermediate Similarity NPD6782 Approved
0.7248 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD943 Approved
0.7219 Intermediate Similarity NPD3926 Phase 2
0.7216 Intermediate Similarity NPD8434 Phase 2
0.72 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6832 Phase 2
0.7192 Intermediate Similarity NPD1610 Phase 2
0.7168 Intermediate Similarity NPD3823 Discontinued
0.7158 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3027 Phase 3
0.7135 Intermediate Similarity NPD7435 Discontinued
0.7128 Intermediate Similarity NPD8151 Discontinued
0.7127 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD4361 Phase 2
0.7119 Intermediate Similarity NPD8150 Discontinued
0.7114 Intermediate Similarity NPD1203 Approved
0.7107 Intermediate Similarity NPD2309 Approved
0.7105 Intermediate Similarity NPD6798 Discontinued
0.7105 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD7199 Phase 2
0.7099 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD37 Approved
0.7089 Intermediate Similarity NPD1652 Phase 2
0.7083 Intermediate Similarity NPD6234 Discontinued
0.7081 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD230 Phase 1
0.7076 Intermediate Similarity NPD2403 Approved
0.7074 Intermediate Similarity NPD7585 Approved
0.7072 Intermediate Similarity NPD6534 Approved
0.7072 Intermediate Similarity NPD6535 Approved
0.7066 Intermediate Similarity NPD4966 Approved
0.7066 Intermediate Similarity NPD4967 Phase 2
0.7066 Intermediate Similarity NPD4965 Approved
0.7053 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD7783 Phase 2
0.7043 Intermediate Similarity NPD7696 Phase 3
0.7043 Intermediate Similarity NPD7698 Approved
0.7043 Intermediate Similarity NPD7697 Approved
0.7039 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD4625 Phase 3
0.7034 Intermediate Similarity NPD1548 Phase 1
0.7021 Intermediate Similarity NPD7583 Approved
0.7012 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD7458 Discontinued
0.7011 Intermediate Similarity NPD1729 Discontinued
0.7005 Intermediate Similarity NPD7871 Phase 2
0.7005 Intermediate Similarity NPD7870 Phase 2
0.7 Intermediate Similarity NPD6190 Approved
0.6994 Remote Similarity NPD7228 Approved
0.6993 Remote Similarity NPD3268 Approved
0.6993 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6823 Phase 2
0.6984 Remote Similarity NPD7701 Phase 2
0.6982 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6981 Remote Similarity NPD2654 Approved
0.6975 Remote Similarity NPD4662 Approved
0.6975 Remote Similarity NPD4661 Approved
0.6968 Remote Similarity NPD6355 Discontinued
0.6968 Remote Similarity NPD1933 Approved
0.6966 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7699 Phase 2
0.6957 Remote Similarity NPD7700 Phase 2
0.6954 Remote Similarity NPD2798 Approved
0.6951 Remote Similarity NPD1653 Approved
0.6948 Remote Similarity NPD6233 Phase 2
0.6943 Remote Similarity NPD4308 Phase 3
0.6933 Remote Similarity NPD5049 Phase 3
0.6919 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6913 Remote Similarity NPD9717 Approved
0.6911 Remote Similarity NPD7874 Approved
0.6911 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6887 Remote Similarity NPD2797 Approved
0.6886 Remote Similarity NPD6844 Discontinued
0.6879 Remote Similarity NPD4538 Approved
0.6879 Remote Similarity NPD4536 Approved
0.6879 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6879 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6875 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7801 Approved
0.6871 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6867 Remote Similarity NPD4749 Approved
0.686 Remote Similarity NPD7229 Phase 3
0.6859 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6859 Remote Similarity NPD447 Suspended
0.6855 Remote Similarity NPD6003 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data